145 related articles for article (PubMed ID: 27760736)
1. A case treated with nivolumab after small cell lung cancer transformation of mutant EGFR non-small cell lung cancer.
Nishikawa S; Tambo Y; Ninomiya H; Oguri T; Kawashima Y; Takano N; Kitazono S; Ohyanagi F; Horiike A; Yanagitani N; Ishikawa Y; Nishio M
Ann Oncol; 2016 Dec; 27(12):2300-2302. PubMed ID: 27760736
[No Abstract] [Full Text] [Related]
2. Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.
Tokaca N; Wotherspoon A; Nicholson AG; Fotiadis N; Thompson L; Popat S
Lung Cancer; 2017 Sep; 111():65-68. PubMed ID: 28838401
[TBL] [Abstract][Full Text] [Related]
3. [A case report of combined small cell lung cancer with EGFR mutation and treatment experience].
Guo Y; Qu L; Shao M; Wang X; Sun H; Ma K
Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):511-4. PubMed ID: 24949695
[No Abstract] [Full Text] [Related]
4. Is FISH floating or still swimming in the lung cancer ocean?
Cappuzzo F; Camidge DR; Varella-Garcia M
Ann Oncol; 2011 Mar; 22(3):493-499. PubMed ID: 21292645
[No Abstract] [Full Text] [Related]
5. A Case of Small Cell Lung Cancer Transformation from EGFR-Mutant Lung Adenocarcinoma with Primary Resistance to Gefitinib.
Chu X; Li Y; Zhu Z
J Thorac Oncol; 2018 Oct; 13(10):e211-e214. PubMed ID: 30244858
[No Abstract] [Full Text] [Related]
6. Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment.
Ham JS; Kim S; Kim HK; Byeon S; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Han J; Park W; Ahn MJ
J Thorac Oncol; 2016 Jan; 11(1):e1-4. PubMed ID: 26762749
[No Abstract] [Full Text] [Related]
7. A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.
van Riel S; Thunnissen E; Heideman D; Smit EF; Biesma B
Ann Oncol; 2012 Dec; 23(12):3188-3189. PubMed ID: 23079729
[No Abstract] [Full Text] [Related]
8. Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
Iijima Y; Hirotsu Y; Mochizuki H; Amemiya K; Oyama T; Uchida Y; Kobayashi Y; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
Clin Lung Cancer; 2018 Nov; 19(6):e843-e847. PubMed ID: 30122430
[No Abstract] [Full Text] [Related]
9. Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.
Takagi Y; Nakahara Y; Hosomi Y; Hishima T
BMC Cancer; 2013 Nov; 13():529. PubMed ID: 24195468
[TBL] [Abstract][Full Text] [Related]
10. Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin.
Hwang KE; Jung JW; Oh SJ; Park MJ; Shon YJ; Choi KH; Jeong ET; Kim HR
Tumori; 2015 Jun; 101(3):e96-8. PubMed ID: 25908039
[TBL] [Abstract][Full Text] [Related]
11. Nivolumab in non-small-cell lung cancer with EGFR mutation.
Yoshida H; Kim YH; Ozasa H; Nagai H; Sakamori Y; Tsuji T; Nomizo T; Yasuda Y; Funazo T; Hirai T
Ann Oncol; 2018 Mar; 29(3):777-778. PubMed ID: 29161357
[No Abstract] [Full Text] [Related]
12. [Clinical Observation of Translating to Small Cell Lung Cancer Following Treatment with EGFR-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma].
Xue S; Yu T; Zhang Y; Shan L
Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):656-60. PubMed ID: 26483340
[TBL] [Abstract][Full Text] [Related]
13. Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?
Zhang Y; Li XY; Tang Y; Xu Y; Guo WH; Li YC; Liu XK; Huang CY; Wang YS; Wei YQ
Lung Cancer; 2013 Aug; 81(2):302-5. PubMed ID: 23683536
[TBL] [Abstract][Full Text] [Related]
14. EGFR mutation in gefitinib-responsive small-cell lung cancer.
Okamoto I; Araki J; Suto R; Shimada M; Nakagawa K; Fukuoka M
Ann Oncol; 2006 Jun; 17(6):1028-9. PubMed ID: 16357019
[No Abstract] [Full Text] [Related]
15. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
[TBL] [Abstract][Full Text] [Related]
16. [New European approvals: Durvalumab - In first line metastatic small-cell lung cancer].
El Kaddissi A; Basse C
Bull Cancer; 2020 Dec; 107(12):1208-1209. PubMed ID: 33187682
[No Abstract] [Full Text] [Related]
17. Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib.
Haratani K; Hayashi H; Watanabe S; Kaneda H; Yoshida T; Takeda M; Shimizu T; Nakagawa K
Ann Oncol; 2016 Jan; 27(1):200-2. PubMed ID: 26483048
[No Abstract] [Full Text] [Related]
18. Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer.
Loochtan AI; Nickolich MS; Hobson-Webb LD
Muscle Nerve; 2015 Aug; 52(2):307-8. PubMed ID: 25759003
[No Abstract] [Full Text] [Related]
19. A case of residual non-small cell lung cancer cells coexisting with newly developed small cell lung cancer cells in ascitic fluid after chemotherapy for non-small cell lung cancer.
Park SH; Chi HS; Kim YJ; Cho YU; Jang S; Park CJ; Kim SW
Ann Lab Med; 2014 Mar; 34(2):163-5. PubMed ID: 24624356
[No Abstract] [Full Text] [Related]
20. Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer.
Hong S; Gao F; Fu S; Wang Y; Fang W; Huang Y; Zhang L
JAMA Oncol; 2018 May; 4(5):739-742. PubMed ID: 29596544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
